Spotlight Correspondence
Leukemia (2003) 17, 634–635. doi:10.1038/sj.leu.2402842
Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones
Y L Chee1, M A Vickers1, D Stevenson1, T L Holyoake2 and D J Culligan1
- 1Departments of Haematology and Cytogenetics, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK
- 2Division of Cancer Sciences and Molecular Pathology, University of Glasgow, Royal Infirmary, Glasgow G31 2ER, UK
Correspondence: DJ Culligan, DJ Culligan, Department of Haematology, Ward 16, ANCHOR Unit, Aberdeen Royal infirmary, Foresterhill Road, Aberdeen AB25 2ZN, UK. Fax: 44 1224 550714
Received 10 October 2002; Accepted 31 October 2002.
